ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update Aug 12, 2025 04:05PM
ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update Mar 6, 2025 04:01PM
ALX Oncology Highlights Focused Evorpacept Development Plan, Clinical Progress and Corporate Updates at R&D Day Webcast Event Mar 5, 2025 08:00AM
ALX Oncology Highlights Focused Evorpacept Development Plan, Clinical Progress and Corporate Updates at R&D Day Webcast Event Mar 5, 2025 08:00AM